Literature DB >> 9516841

Delimitation of a critical tumour suppressor region at distal 1p in neuroblastoma tumours.

T Martinsson1, R M Sjöberg, K Hallstensson, M Nordling, F Hedborg, P Kogner.   

Abstract

We analysed DNA from 68 neuroblastoma tumours for loss of heterozygosity (LOH) on the distal chromosome 1p (1p-LOH) using PCR-based DNA polymorphisms. Fifteen tumours (22%) displayed 1p-LOH. The shortest region of overlap (SRO) for the deletions was defined proximally by marker D1S244 and distally by marker D1S80. The CDC2L1 locus, located on chromosome 1p36, has been put forward as a neuroblastoma tumour suppressor. We analysed coding regions of the CDC2L1 gene in a subset of aggressive neuroblastoma tumours with known allelic loss for different 1p-markers. Single-stranded conformation polymorphism, heteroduplex and sequencing analysis of tumour DNA did not reveal any significant changes in the coding region. Using a DNA sequence polymorphism, we showed, in a primary tumour with an interstitial allelic deletion, that this tumour had both alleles of the CDC2L1 locus retained in the tumour. Thus, we showed that the neuroblastoma tumour suppressor critical region on 1p in our material is defined by loci D1S244 and D1S80 and that the CDC2L1 locus is distal to the critical region.

Entities:  

Mesh:

Year:  1997        PMID: 9516841     DOI: 10.1016/s0959-8049(97)00278-5

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  17 in total

Review 1.  The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis.

Authors:  Raquel Domingo-Fernandez; Karen Watters; Olga Piskareva; Raymond L Stallings; Isabella Bray
Journal:  Pediatr Surg Int       Date:  2012-12-29       Impact factor: 1.827

Review 2.  Monosomy 1p36.

Authors:  A Slavotinek; L G Shaffer; S K Shapira
Journal:  J Med Genet       Date:  1999-09       Impact factor: 6.318

3.  Mechanisms of CHD5 Inactivation in neuroblastomas.

Authors:  Hiroshi Koyama; Tiangang Zhuang; Jennifer E Light; Venkatadri Kolla; Mayumi Higashi; Patrick W McGrady; Wendy B London; Garrett M Brodeur
Journal:  Clin Cancer Res       Date:  2012-01-31       Impact factor: 12.531

Review 4.  Energy metabolism in neuroblastoma and Wilms tumor.

Authors:  Sepideh Aminzadeh; Silvia Vidali; Wolfgang Sperl; Barbara Kofler; René G Feichtinger
Journal:  Transl Pediatr       Date:  2015-01

5.  Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death.

Authors:  Katarina Ejeskär; Cecilia Krona; Helena Carén; Faten Zaibak; Lingli Li; Tommy Martinsson; Panayiotis A Ioannou
Journal:  BMC Cancer       Date:  2005-12-16       Impact factor: 4.430

6.  Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes.

Authors:  Kaisa Thorell; Annika Bergman; Helena Carén; Staffan Nilsson; Per Kogner; Tommy Martinsson; Frida Abel
Journal:  BMC Med Genomics       Date:  2009-08-17       Impact factor: 3.063

7.  The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy.

Authors:  Nadine Van Roy; Katleen De Preter; Jasmien Hoebeeck; Tom Van Maerken; Filip Pattyn; Pieter Mestdagh; Joëlle Vermeulen; Jo Vandesompele; Frank Speleman
Journal:  Genome Med       Date:  2009-07-27       Impact factor: 11.117

8.  A novel 1p36.2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma tumours.

Authors:  C Krona; K Ejeskär; H Carén; F Abel; R-M Sjöberg; T Martinsson
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

9.  A cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylation.

Authors:  Helena Carén; Katarina Ejeskär; Susanne Fransson; Luke Hesson; Farida Latif; Rose-Marie Sjöberg; Cecilia Krona; Tommy Martinsson
Journal:  Mol Cancer       Date:  2005-03-01       Impact factor: 27.401

10.  Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma.

Authors:  D Astuti; M Morris; C Krona; F Abel; D Gentle; T Martinsson; P Kogner; H P H Neumann; R Voutilainen; C Eng; P Rustin; F Latif; E R Maher
Journal:  Br J Cancer       Date:  2004-11-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.